Cargando…

First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride

Raloxifene is a drug used in postmenopausal women with osteoporosis. Although hot flashes are known side effects of raloxifene, to the best of our knowledge, erythema multiforme (EM) minor has not been previously reported. Herein, we report about a 74-year-old woman who developed EM minor after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Norimatsu, Yurie, Norimatsu, Yuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460885/
https://www.ncbi.nlm.nih.gov/pubmed/34720916
http://dx.doi.org/10.1159/000519029
_version_ 1784571856263577600
author Norimatsu, Yurie
Norimatsu, Yuta
author_facet Norimatsu, Yurie
Norimatsu, Yuta
author_sort Norimatsu, Yurie
collection PubMed
description Raloxifene is a drug used in postmenopausal women with osteoporosis. Although hot flashes are known side effects of raloxifene, to the best of our knowledge, erythema multiforme (EM) minor has not been previously reported. Herein, we report about a 74-year-old woman who developed EM minor after the drug alfacalcidol was changed to raloxifene to treat osteoporosis. Skin biopsy revealed a suspicious eczematous drug reaction. The drug-induced lymphocyte stimulation test showed a positive result. The stimulation index was 2.2, and there were no other suspected drugs. Based on these results, we diagnosed the condition as EM minor caused by raloxifene. The patient's symptoms disappeared after the use of antihistamine drugs and topical steroids. In conclusion, raloxifene can cause EM minor in rare cases.
format Online
Article
Text
id pubmed-8460885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-84608852021-10-28 First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride Norimatsu, Yurie Norimatsu, Yuta Case Rep Dermatol Single Case Raloxifene is a drug used in postmenopausal women with osteoporosis. Although hot flashes are known side effects of raloxifene, to the best of our knowledge, erythema multiforme (EM) minor has not been previously reported. Herein, we report about a 74-year-old woman who developed EM minor after the drug alfacalcidol was changed to raloxifene to treat osteoporosis. Skin biopsy revealed a suspicious eczematous drug reaction. The drug-induced lymphocyte stimulation test showed a positive result. The stimulation index was 2.2, and there were no other suspected drugs. Based on these results, we diagnosed the condition as EM minor caused by raloxifene. The patient's symptoms disappeared after the use of antihistamine drugs and topical steroids. In conclusion, raloxifene can cause EM minor in rare cases. S. Karger AG 2021-09-13 /pmc/articles/PMC8460885/ /pubmed/34720916 http://dx.doi.org/10.1159/000519029 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Norimatsu, Yurie
Norimatsu, Yuta
First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
title First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
title_full First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
title_fullStr First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
title_full_unstemmed First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
title_short First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
title_sort first report of erythema multiforme minor caused by raloxifene hydrochloride
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460885/
https://www.ncbi.nlm.nih.gov/pubmed/34720916
http://dx.doi.org/10.1159/000519029
work_keys_str_mv AT norimatsuyurie firstreportoferythemamultiformeminorcausedbyraloxifenehydrochloride
AT norimatsuyuta firstreportoferythemamultiformeminorcausedbyraloxifenehydrochloride